IgG antibodies are commonly used in cancer treatment. They help the body's immune system fight cancer and are being ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

Global Bispecific Trispecific Antibodies Market Size Will Surpass US$ 50 Billion By 2030 Says Kuick ResearchDelhi, April 04, ...

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and ...

The biotech has already initiated discussions with potential partners for evalstotug, an anti–CTLA-4 monoclonal antibody in phase 1 and 2 studies for a range of tumor types. “We are encouraged ...

Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.

Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an ...

"By doing that, the antibody has significantly prolonged survival in brain tumor models by itself -- without radiation or chemotherapy." Cold tumors, sometimes called immune deserts, typically do ...

a tumor necrosis factor-alpha (TNF-α) inhibitor, in serum with concentrations detected being significantly higher than the standard serum trough concentration needed for antibody efficacy in ...